Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet

NCT03389061 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03389061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03389061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Withdrawn
Start date
April 1, 2018
Completion date
March 22, 2019
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hcv